ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735532 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735532; 2) Community: the network communities that were significantly associated with the response to NSC 735532; 3) Molecule: the relationships between components within communities and NSC 735532; 4) MDR: the compounds that were significantly associated with the NSC 735532.

NSC Compound Enrichment Correlation
NSC 665740 Null 0.0395466756030202 -0.092799513
NSC 720992 Null 0.0395466756030202 0.32371891
NSC 721041 Null 0.0395466756030202 0.22751852
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.0395466756030208 -0.058031115
NSC 127328 Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- 0.0396077140933374 -0.016725758
NSC 215721 Null 0.0396077140933374 0.24542057
NSC 640084 Null 0.0396077140933374 0.24757318
NSC 648365 Insulin-Methotrexate conjugate 0.0396077140933374 0.06587443
NSC 651774 Null 0.0396077140933374 0.078009666
NSC 742838 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl-, hydrochloride 0.0396077140933377 0.071717168
Total:44  Current:35    [First] [Prev] [Next] [Last]